Tabula Rasa HealthCare Inc (NASDAQ:TRHC) major shareholder Growth Fund 1Q Lp Originate sold 684,180 shares of the business’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $25.85, for a total value of $17,686,053.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Tabula Rasa HealthCare Inc (TRHC) traded down $0.01 during mid-day trading on Tuesday, hitting $28.59. The stock had a trading volume of 153,500 shares, compared to its average volume of 105,992. Tabula Rasa HealthCare Inc has a 1-year low of $11.59 and a 1-year high of $36.80. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.66 and a current ratio of 0.73.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its earnings results on Monday, November 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.02. The business had revenue of $33.27 million for the quarter, compared to analyst estimates of $31.76 million. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The business’s quarterly revenue was up 37.6% on a year-over-year basis. During the same period last year, the company posted $0.06 EPS. equities research analysts predict that Tabula Rasa HealthCare Inc will post 0.05 EPS for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the stock. TIAA CREF Investment Management LLC raised its position in Tabula Rasa HealthCare by 108.5% in the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock valued at $110,000 after purchasing an additional 4,232 shares during the period. New York State Common Retirement Fund raised its position in Tabula Rasa HealthCare by 257.0% in the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock valued at $151,000 after purchasing an additional 7,199 shares during the period. Cadence Capital Management LLC purchased a new position in Tabula Rasa HealthCare in the second quarter valued at about $210,000. Financial Consulate Inc. purchased a new position in Tabula Rasa HealthCare in the third quarter valued at about $222,000. Finally, Teachers Advisors LLC raised its position in Tabula Rasa HealthCare by 203.5% in the second quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock valued at $248,000 after purchasing an additional 11,063 shares during the period. 31.85% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages have recently issued reports on TRHC. Zacks Investment Research downgraded Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 10th. Piper Jaffray Companies restated an “overweight” rating and issued a $29.00 price target (up previously from $20.00) on shares of Tabula Rasa HealthCare in a report on Wednesday, September 20th. UBS upped their price target on Tabula Rasa HealthCare from $18.00 to $25.00 and gave the stock a “buy” rating in a report on Wednesday, August 30th. Wells Fargo & Company upped their price target on Tabula Rasa HealthCare from $21.00 to $27.00 and gave the stock a “market perform” rating in a report on Thursday, October 19th. Finally, ValuEngine upgraded Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a report on Saturday, September 30th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Tabula Rasa HealthCare presently has an average rating of “Buy” and a consensus target price of $28.25.

TRADEMARK VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/12/tabula-rasa-healthcare-inc-trhc-major-shareholder-sells-17686053-00-in-stock.html.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.